Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 10,858

Document Document Title
WO/2016/188766A1
The present invention relates to compounds for prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially to compounds for prophylaxis or treatment of di...  
WO/2016/190750A1
Improving the antioxidant capacity in an animal by increasing the level of glutathione in the blood or tissue of the animal comprising providing a composition containing beta- casein to the animal for consumption, where the beta-casein c...  
WO/2016/187545A1
This invention relates to compositions and methods for treating, ameliorating and preventing the toxic effects of venom poisoning. In particular, the invention provides compositions comprising carbon monoxide releasing molecules (CORM) o...  
WO/2016/185403A1
The present application refers to the development of a new effective antidote for the poisonous Amanita mushroom species, after exploring an innovative in silico and in vivo approach based on the binding site of amatoxin to RNA polymeras...  
WO/2016/177309A1
Provided is a method for preparing a broccoli protein peptide. The method uses a broccoli protein as the raw material, and obtains a broccoli protein peptide powder through the steps of preprocessing, enzymatic hydrolysis, terminating en...  
WO/2016/174367A1
The present invention relates to a bioassimilable protein-melanin complex, advantageously soluble in water, comprising a protein extract, advantageously rich in S-sulfonated residues and melanin. The claimed complex further exhibits subs...  
WO/2016/171640A1
The invention relates to pharmacology and may be used for producing medicinal agents for treating and preventing viral diseases caused by the herpes, influenza and hepatitis B and C viruses, and also virus-induced immunodeficiencies. A b...  
WO/2016/169353A1
A compound beverage for clearing heat and a preparation method therefor. The compound beverage is prepared from the following components in parts by weight: 15 to 20 parts of white fungus, 3 to 7 parts of bulbus lilii, 1 to 5 parts of se...  
WO/2016/168670A3
The present disclosure relates to methods of extending the lifespan of a subject or treating, suppressing, inhibiting or delaying the onset of an age-related condition or disorder, such as cancer, in a subject. The methods comprise admin...  
WO/2016/161501A1
The present application provides pharmaceutical compositions comprising polyanionic and polynon-ionic cyclodextrin-based dendrimers. The compositions can be used as excipients, or to bind to compounds such as in the use as a rescue medic...  
WO/2016/162870A1
Inhibitor compounds and agents of Cathepsin C, CELA1, CELA3A and/or structurally related molecules thereto, compositions comprising same and uses thereof in the inhibition and/or prevention of cell and/or tissue necrosis is described. Va...  
WO/2016/149886A1
Uses of a multipolar microkinetic drinking water in preparing a drink, healthcare product or medicament for use in reducing blood urea. The multipolar microkinetic drinking water is prepared from raw drinking water being passed through a...  
WO/2016/149885A1
Uses of a multipolar microkinetic drinking water in preparing a drink, healthcare product or medicament for reducing blood urea. The multipolar microkinetic drinking water is prepared from raw drinking water being passed through an elect...  
WO/2016/147185A1
Novel adenosine 5'-thiophosphate derivatives, represented by Formulae (I) or (I*), and salts thereof, represented by Formulae (Ia) and (I*a), as defined in the specification, and uses thereof as antioxidants and/or P2Y1-R agonists, and/o...  
WO/2016/148202A1
Provided is a method for producing functional mineral water having antioxidative effect and other effective indications. Provided is a method for producing functional mineral water containing: a mineral-containing water (A) that contains...  
WO/2016/149424A1
Compositions comprising apple, grape, green tea, and olive extracts are presented herein. This synergistic formulations apple, grape, green tea, and olive extract are in amounts that provide a greater antioxidant activity or protein kina...  
WO/2016/145911A1
An application of nicotinamide mononucleotide in the preparation of an anti-aging drug or health care product, a single dose of nicotinamide mononucleotide being 1-500mg/kilogram of body weight/day, the drug or health care product being ...  
WO/2016/146573A1
Compositions comprising melatonin and/or derivatives thereof are provided for topical administration to the epithelium of the urinary bladder by instillation into the bladder to protect against or treat bladder injury due to irradiation ...  
WO/2016/146042A1
The present invention provides a zinc binding fusion protein that is a fusion protein of glutathione S-transferase (GST) and metallothionein (MT) binding to zinc, which provides an efficacy in preventing or treating a ROS-related disease...  
WO/2016/142580A1
The present invention concerns a non-toxic solid pharmaceutical composition for oral administration for use in preventing hangover symptoms, wherein the composition contains one or more cysteine compounds from the group of L-cysteine, D-...  
WO/2016/141775A1
Uses of Jilin ginseng oligopeptide in preparing a food product or healthcare food product for combating fatigue.  
WO/2016/142341A1
Compositions comprising melatonin or derivatives thereof are provided for topical administration to the vaginal and/or rectal epithelium to protect against vaginal and/or rectal radiation injury due to radiotherapy.  
WO/2016/141315A1
Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and/or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two s...  
WO/2016/135666A1
This invention relates to a liquid aqueous composition liquid aqueous composition for the prevention, reduction and/or treatment of burns caused by contacting of the skin of a body part of a human or animal with one or more chemicals, wh...  
WO/2016/131972A1
The invention relates to the use of Dasatinib in the preparation of a drug for treating a mammal exposed to radiation, in particular abdominopelvic radiation exposure, for preventing, limiting, reducing and/or eliminating the early or la...  
WO/2016/131333A1
Provided are an antioxidant complex for reducing the number of somatic cells in a livestock animal and a preparation method and application thereof. Active components of the preparation are melatonin (MT) having a concentration of 2-30 g...  
WO/2016/130927A1
Disclosed herein are compounds of the formula: (I), wherein the variables are defined herein. Also provided are pharmaceutical compositions thereof. In some aspects, the compounds and compositions provided herein may be used as antioxida...  
WO/2016/127896A1
Disclosed is an application of an antibacterial peptide C-BF in preparation of a drug for preventing and treating stress of weaned piglets. The antibacterial peptide C-BF can improve intestinal morphology, increase the height of villi, r...  
WO/2016/124605A1
Compositions comprising melatonin or derivatives thereof for administration to the epithelium of the lower airway to protect against lung damage due to chest irradiation and/or cytotoxic chemotherapy are provided.  
WO/2016/126860A1
Provided are pharmaceutical dosage forms comprising (i) trientine or a pharmaceutically acceptable salt of trientine, in a (ii) sealed packaging. The sealed packaging provides a high barrier protection against air, moisture and light and...  
WO/2016/125006A1
The invention provides an isolated, engineered, non-naturally occurring tissue protective protein or peptide (TPP) comprising a cell penetrating peptide (CPP) fused in frame with a heme oxygenase protein, or a derivative, variant, homolo...  
WO/2016/119143A1
A lutein microcapsule preparation and preparation method, the preparation comprising the following ingredients: lutein crystals, a water-soluble emulsifier, an oil-soluble antioxidant, a wall material, a filler, a water-soluble antioxida...  
WO/2016/118611A1
Bifunctional compounds that increase uric acid excretion and reduce uric acid production, and monofunctional compounds that either increase uric acid excretion or reduce uric acid production. Methods of using these compounds for reducing...  
WO/2016/118878A1
A supplement includes plant-derived phosphatidylserine in a physiologically beneficial amount and at least one plant-based concentrate or extract which promotes a melatonergic benefit.  
WO/2016/114860A1
Compounds, compositions, and methods for treatment of, or prophylaxis against, radiation exposure are disclosed.  
WO/2016/115097A3
The present invention provides methods and compositions for specific activation of inflammatory responses in dendritic cells (DCs). 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (PAPC) and its oxidized variant (oxPAPC) were id...  
WO/2016/115097A2
The present invention provides methods and compositions for specific activation of inflammatory responses in dendritic cells (DCs). 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (PAPC) and its oxidized variant (oxPAPC) were id...  
WO/2016/111265A1
The present invention provides an antioxidant agent containing an enzymatically synthesized glycogen (ESG) or an α-amylase digest (RG) thereof, an active oxygen inhibitor, antioxidant enzyme production promotor, an antioxidant cosmetic,...  
WO/2016/112381A1
Provided are methods of treating a disease or condition characterized by a deficiency of or a defect in an iron transporter using a small molecule. For example, the method may increase transepithelial iron transport, or it may increase i...  
WO/2016/109856A1
This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.  
WO/2016/107850A1
The invention relates to a method for obtaining a superoxide dismutase (SOD)-concentrated protein extract having a specific activity of at least 700 UI/mg protein, said method comprising a single step of extraction from a plant selected ...  
WO/2016/109002A3
This invention relates, in part, to methods and compositions that are useful for the treatment and/or prevention of various disorders, including radiation-related disorders, such as acute radiation syndrome.  
WO/2016/103544A1
[Problem] To provide a novel food or drink capable of reducing alcohol concentration in blood. [Solution] A food or drink containing one or more kinds of dietary fiber components selected from the group consisting of xanthan gum, glucoma...  
WO/2016/092235A1
The invention relates to the use of a composition comprising at least one extract of propolis, having at least one of the following properties: ‐ an antioxidant value (ORAC) greater than or equal to 500 mmol TE/100g of dry extract, ‐...  
WO/2016/088816A1
Provided are: a compact-sized granulate of zinc acetate hydrate, in which the loss of crystallization water is suppressed during a manufacturing process by controlling the material temperature of the granulate to lower than 40°C during ...  
WO/2016/088700A1
[Problem] To provide a method for efficient commercial manufacture of a composition containing a sweetness component from Siraitia grosvenorii, the composition containing a high concentration of mogrosides, producing a pleasant sweet qua...  
WO/2016/089200A1
The present invention discloses an antimicrobial, antioxidant and natural preservative comprising of palm-derived carotenoid rich oil, including but not limited to, red palm oil and it's fractions that could be in the form of whole and/o...  
WO/2016/087667A1
The present invention relates to chelates resulting from the complexation of bifunctional do2pa derivatives ligands of formula (I), wherein the substituents R1, R1', R2, R2', R3, R3', L1, L1', L2 and L2' are defined as in the claims, wit...  
WO/2016/084029A1
The present invention relates to selected strains of bacteria belonging to the genus Lactobacillus and Bifidobacteria being able to maintaining a long-lasting homeostasis condition in a human body. Furthermore, the present invention rela...  
WO/2016/082703A1
A preparation containing a chlorogenic acid crystal form. The crystal form is an orthorhombic crystal system, a space group is P2 12 12 1, cell parameters are as follows: a=7.7291(2)Å, b=10.9808(2)Å, c=36.5334(7)Å, α=β=γ=90.00°, Z...  

Matches 1 - 50 out of 10,858